Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,370.00
-130.00 (-5.20%)
Last updated: Jun 24, 2026, 1:24 PM KST

Aprogen Medicines Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-73,268-70,202-58,079-55,619-98,657-93,920
Depreciation & Amortization
23,29023,59724,30529,07128,39225,262
Loss (Gain) From Sale of Assets
2,7912,786201.14-30.3457.39-
Asset Writedown & Restructuring Costs
798.31739.83801.872,2719,162223.61
Loss (Gain) From Sale of Investments
-2,600-1,749-303-341.932,7441,228
Loss (Gain) on Equity Investments
39,92839,375--1,4899,543
Stock-Based Compensation
729.411,1521,7181,613707.672,445
Provision & Write-off of Bad Debts
46.23384.751,573-8.5-5,001-
Other Operating Activities
-53,397-56,850-18,663-19,249-35,587-17,926
Change in Accounts Receivable
834.983,558-207.691,7493,395778.84
Change in Inventory
-11,695-4,0301,270-5,024-17,526-8,367
Change in Accounts Payable
8,103-2,683-4,369-3,491-1,8523,378
Change in Income Taxes
-222.7-222.7-217.8935.78770.88
Change in Other Net Operating Assets
-1,69831,4876,761-9,315-2,151-8,155
Operating Cash Flow
-66,361-32,657-44,992-58,156-113,491-84,740
Capital Expenditures
-5,820-8,994-12,671-25,514-19,610-34,392
Sale of Property, Plant & Equipment
344.8373.3483.042,273131.6540.06
Cash Acquisitions
-5,080-5,080-127.87-39,940-
Divestitures
58,12158,122300-29,285-
Sale (Purchase) of Intangibles
-12,239-11,931-10,473-29,371-5,209-474.06
Investment in Securities
15,703-59,583-9,486965.6827,26818,390
Other Investing Activities
-34,515-36,702-8,1308,193-1,690-924.3
Investing Cash Flow
16,516-63,795-40,504-43,45270,172-12,790
Short-Term Debt Issued
-37,50011,05014,61096,500134,190
Long-Term Debt Issued
-158,83536,35096,546-30,845
Total Debt Issued
114,339196,33547,400111,15696,500165,035
Short-Term Debt Repaid
--12,300-11,350-40,110-7,500-27,000
Long-Term Debt Repaid
--82,560-12,967-8,481-1,873-30,220
Total Debt Repaid
-72,990-94,860-24,317-48,591-9,373-57,220
Net Debt Issued (Repaid)
41,349101,47523,08362,56587,127107,815
Issuance of Common Stock
--0.765,51530.972,583
Repurchase of Common Stock
---0.1--15,791-
Dividends Paid
-0.08-0.08----
Other Financing Activities
1,4181,46763,53726,216-561.9-0
Financing Cash Flow
42,767102,94186,62194,29670,804110,398
Foreign Exchange Rate Adjustments
1,9941,497352.04-72.93-309.074.05
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
-5,0847,9871,477-7,38527,17612,872
Free Cash Flow
-72,181-41,651-57,662-83,669-133,101-119,132
Free Cash Flow Margin
-56.59%-35.30%-38.41%-55.57%-169.88%-453.05%
Free Cash Flow Per Share
-3581.95-2100.37-3350.77-5314.11-9864.93-10307.07
Cash Interest Paid
2,7712,821630.7242.7610,99211,339
Cash Income Tax Paid
3,2182,921220.01-2,1283,291398.92
Levered Free Cash Flow
-152,660-91,444-41,649-21,656-145,21326,095
Unlevered Free Cash Flow
-148,746-88,467-41,019-21,261-139,02239,697
Change in Working Capital
-4,67828,1103,454-15,862-17,199-11,594